JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 11, 2007; DOI: 10.1124/jpet.107.122812


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.122812v1
322/1/378    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madejczyk, M. S
Right arrow Articles by Ballatori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madejczyk, M. S
Right arrow Articles by Ballatori, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLCYSTEINE


Received for publication March 15, 2007.
Revised April 6, 2007.
Accepted for publication April 10, 2007.

Accelerated urinary excretion of methylmercury following administration of its antidote N-acetylcysteine requires Mrp2/Abcc2, the apical multidrug resistance-associated protein

Michael S Madejczyk 1, David A Aremu 1, Tracey A. Simmons-Willis 2, Thomas W Clarkson 1, Nazzareno Ballatori 3*

1 University of Rochester School of Medicine 2 Texas Southern University 3 University of Rochester Medical Center

* Address correspondence to: E-mail: ned_ballatori{at}urmc.rochester.edu

Abstract

N-Acetylcysteine (NAC) is a sulfhydryl-containing compound that produces a dramatic acceleration of urinary methylmercury (MeHg) excretion in poisoned mice, but the molecular mechanism for this effect is poorly defined. MeHg readily binds to NAC to form the MeHg-NAC complex, and recent studies indicate that this complex is an excellent substrate for the basolateral organic anion transporter-1, Oat1/Slc22a6, thus potentially explaining the uptake from blood into the renal tubular cells. The present study tested the hypothesis that intracellular MeHg is subsequently transported across the apical membrane of the cells into the tubular fluid as a MeHg-NAC complex utilizing the multidrug resistance-associated transporter-2 (Mrp2/Abcc2). NAC markedly stimulated urinary [14C]MeHg excretion in wild type Wistar rats, and a second dose of NAC was as effective as the first dose in stimulating MeHg excretion. In contrast with the normal Wistar rats, NAC was much less effective at stimulating urinary MeHg excretion in the Mrp2-deficient (TR-) Wistar rats. The TR- rats excreted only ~30% of the MeHg excreted by the wild type animals. To directly test whether MeHg-NAC is a substrate for Mrp2, studies were carried out in plasma membrane vesicles isolated from livers of TR- and control Wistar rats. Transport of MeHg-NAC was lower in vesicles prepared from from TR- rats, whereas transport of MeHg-cysteine was similar in control and TR- rats. These results indicate that Mrp2 is involved in urinary MeHg excretion after NAC administration, and suggest that the transported molecule is most likely the MeHg-NAC complex.


Key words: Antidote, Membrane transport, Methylmercury, Mrp2, multidrug resistance-associated protein-2, N-Acetylcysteine, Urinary excretion mechanism





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.